Tower-Medic Pharmacy is categorized under Mail Order Pharmaceuticals in Fort Worth, TX and active since 2002.
Tower-Medic Pharmacy was established in 2002, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Mail Order Pharmaceuticals business, which does work in the B2C market, and is classified as a Mail Order Pharmaceuticals, under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Melvin Musgrove, Owner at the company’s single location by writing to 607 West Magnolia Avenue, Fort Worth, Texas TX 76104 or by phoning (817) 336-8133. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Tower-Medic Pharmacy |
Contact Person: | Melvin Musgrove, Owner |
Address: | 607 West Magnolia Avenue, Fort Worth, Texas 76104 |
Phone Number: | (817) 336-8133 |
Website Address: | towermedic.com |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 2002 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Mail Order Pharmaceuticals |
SIC Code: | 5961 |
NAICS Code: | 4461100 |
Share This Business: |
Tower-Medic Pharmacy was started in 2002 to provide professional Mail Order Pharmaceuticals under the SIC code 5961 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Melvin Musgrove, Owner for inquiries that concern Tower-Medic Pharmacy by calling the company number (817) 336-8133, as your correspondence is most welcome. Additionally, the physical location of the single location of Tower-Medic Pharmacy can be found at the coordinates 32.730616,-97.331319 as well as the street address 607 West Magnolia Avenue in Fort Worth, Texas 76104.
For its online presence, you may visit Tower-Medic Pharmacy’s website at towermedic.com and engage with its social media outlets through on Twitter and on Facebook.